Search academic texts

Information × Registration Number 0220U100549, 0115U002763 , R & D reports Title Clinical-pathogenetical substantiation of differentiated methods of treatment of patients with arterial hypertention, diffuse damage of the liver of nonviral origin and chronic dermatoses taking into account state of endocrine, immune systems, gut biocenosis and metabolic processes popup.stage_title Head Ilashuk Tetiana O., Доктор медичних наук Registration Date 21-01-2020 Organization HSEE of Ukraine "Bukovinian State Medical University" popup.description2  Object of the study: metabolic syndrome in women with dyshormonal-dysovarial disorders, non-alcoholic fatty liver disease, chronic non-viral hepatitis, chronic dermatoses (acne, rosacea, allergodermatoses, psoriasis, red plaque). The aim – to substantiate differentiated methods of treatment of patients with arterial hypertension, diffuse lesions of liver of nonviral origin and chronic dermatoses taking into account the state of endocrine, immune system, intestinal biocenosis and metabolic processes. Research methods: general clinical, biochemical, enzyme immunoassay, questionnaire, instrumental, statistical. In the final report of the complex research of the departments of Propedeutics of Internal Diseses and Dermatovenereology, the peculiarities of the development of metabolic syndrome and arterial hypertension in women of perimenopausal period of life are analyzed. The age and gender aspects of biochemical, pro- and antioxidant parameters, lipid, cytokine and adipokine blood profiles, parameters of ultrasonographic examination of liver and heart in patients with non-alcoholic fatty liver disease were studied. The dynamics of these indicators in the process of application of the treatment scheme with the inclusion of quercetin was investigated. The use of differentiated methods of treatment of chronic dermatoses (rosacea, eczema, psoriasis, allergic dermatoses, acne, red plaque) is justified taking into account the state of the prooxidant-antioxidant system, the level of mediators of inflammation, the degree of intestinal dysbiosis. Successfully tested treatment regimens with the inclusion of probiotic, immunomodulatory, hepatoprotective, antioxidant and disinfectant agents. Product Description popup.authors Ilashuk Tetiana O. Bachuk-Ponych Nataliia V. Brodovska Nadiya B. Voloshyn Olexandr I. Gayevs'ka Maryna Yu. Glubochenko Olena V. Guley Liliya O. Denysenko Olga I. Doholich Oleksandra I. Karvatska Yuliya P. Lukashevych Inna V. Mikulets Lyudmila V. Malkovych Nataliya M. Mykytyuk Oksana P. Okipnyak Iryna V. Perepichka Mykhaylo P. Prysyazhnyuk Vasyl P. Senyuk Bohdana P. Stepan Natalia A. Storozhuk Maryna V. popup.nrat_date 2020-04-02 Close